HLA association in aspirin-intolerant asthma: DPB1*0301 as a strong marker in a Korean population
about
Genetic variants in the major histocompatibility complex class I and class II genes are associated with diisocyanate-induced asthmaWhat we know about nonsteroidal anti-inflammatory drug hypersensitivityProgress in understanding the genomic basis for adverse drug reactions: a comprehensive review and focus on the role of ethnicityAssociation of thromboxane A2 receptor gene polymorphism with the phenotype of acetyl salicylic acid-intolerant asthmaGenetic markers for differentiating aspirin-hypersensitivityAssociation of TNF-alpha genetic polymorphism with HLA DPB1*0301The human leucocyte antigen-DRB1*1302-DQB1*0609-DPB1*0201 haplotype may be a strong genetic marker for aspirin-induced urticariaCirculating autoantibodies in patients with aspirin-intolerant asthma: an epiphenomenon related to airway inflammationGenome-wide association study identifies HLA-DP as a susceptibility gene for pediatric asthma in Asian populationsHuman leucocyte antigen-adverse drug reaction associations: from a perspective of ethnicity.Genome-wide and follow-up studies identify CEP68 gene variants associated with risk of aspirin-intolerant asthma.Hypersensitivity to Aspirin and other NSAIDs: Diagnostic Approach in Patients with Chronic Rhinosinusitis.Nonsteroidal anti-inflammatory drug hypersensitivity in preschool children.The SNP rs3128965 of HLA-DPB1 as a genetic marker of the AERD phenotypeHLA and Disease Associations in Koreans.Flow Cytometry-Assisted Basophil Activation Test as a Safe Diagnostic Tool for Aspirin/NSAID Hypersenstivity.WDR46 is a Genetic Risk Factor for Aspirin-Exacerbated Respiratory Disease in a Korean PopulationPharmacogenetics of aspirin-intolerant asthma.Association of HLA-DRB1 Gene Polymorphism with Risk of Asthma: A Meta-Analysis.Exploration of the Sphingolipid Metabolite, Sphingosine-1-phosphate and Sphingosine, as Novel Biomarkers for Aspirin-exacerbated Respiratory Disease.Update on recent advances in the management of aspirin exacerbated respiratory disease.Unraveling the genetic basis of aspirin hypersensitivity in asthma beyond arachidonate pathways.Genetic and Epigenetic Components of Aspirin-Exacerbated Respiratory Disease.Genetic mechanisms in aspirin-exacerbated respiratory disease.Potential Biomarkers for NSAID-Exacerbated Respiratory DiseaseDigging up the human genome: current progress in deciphering adverse drug reactions.Genetic association analysis of TAP1 and TAP2 polymorphisms with aspirin exacerbated respiratory disease and its FEV1 decline.An update on the management of aspirin-exacerbated respiratory disease.Differential gene expression profile in PBMCs from subjects with AERD and ATA: a gene marker for AERD.Genome-wide association study of aspirin-exacerbated respiratory disease in a Korean population.Genetic variations in KIFC1 and the risk of aspirin exacerbated respiratory disease in a Korean population: an association analysis.A study of the association of childhood asthma with HLA alleles in the population of Siliguri, West Bengal, India.Samter's Triad: State of the Art.Personalized medicine for HLA-associated drug-hypersensitivity reactions
P2860
Q23910397-57B45493-3934-4257-B592-E502C40F5448Q26749250-D5741ABD-7E93-4422-86A8-52F0377D1935Q28083100-FA6F68C8-D1E5-4BC1-85AF-964516EB278DQ28175608-70581107-2ED5-4A49-B79C-314568033A0DQ28195398-5AA9A471-B532-4330-8ADF-F56E5C166FDEQ28200594-8DE9D8C3-2322-4145-9BB6-6EC136D345BDQ28211172-21FE718F-19D0-4B98-86EE-29D3B3BF25BFQ28219147-AF4821B1-F05E-4681-A812-3A65173C6E7FQ28943502-4B5886C6-F529-44A0-827F-5CD5398302C0Q30238992-0A138305-EB00-4083-B8F8-0B4C9BDF3B35Q30396182-3BC07742-0483-4F33-9F2B-77BE18C9112CQ30407185-EE3D10FC-0EAE-49DA-BFA6-7CA67DF0626FQ33864878-80690F13-0CF0-4688-9CD2-1FBA8829C60FQ34764489-DA61F0F0-BBF0-454D-8609-0B9B9047B022Q35745487-09389FD1-5ABF-4182-9E5C-2EB4F2784154Q35895191-7559306D-5484-4373-AF12-98200EC45CAFQ36044985-CC8A78D8-76E5-402A-9560-783A6781DACBQ37043508-C3F9AC06-9161-4DF8-B8FE-916AAF2FF4F1Q37186932-9DA43358-B62C-4030-939B-79F80AA1D324Q37405580-D12DF377-2674-4A04-B748-D789D4FC0178Q37485583-76CCC5D4-E3E2-4E0F-8F25-7B459E6F2E5AQ38134073-4A229CAA-84BD-4067-979A-3A68CFBF0349Q38973971-BC2DC06A-8730-4B38-83F3-30959B71C020Q39718340-4E4EE4DA-26CA-42E0-8D9A-9F185B8893F2Q41500425-EECF9399-B561-42D4-8E05-7FF020D2894AQ41889353-752548F0-243F-4B7A-A7AD-EFF9F808F179Q42728692-0CBF0063-549D-4357-9E73-56EB72BC779AQ47678797-088848B7-129E-4135-ADE0-A183C510CDD9Q51540951-D6A33A0A-5488-4BA9-9A6D-FCF6E4D6C392Q53352652-64765738-FA15-4CD8-B9FF-8AFF862A8864Q53393392-D201CF37-729D-4DF1-9C49-45F9C21930E9Q54200919-5FB337EA-AEAA-418D-9A42-AD52FB26E242Q54940852-2AB9C73B-64DA-4E57-84C3-A7B9826F1F39Q57223243-2F8E8B2B-8FE2-4A6B-998B-21FC34BA8F18
P2860
HLA association in aspirin-intolerant asthma: DPB1*0301 as a strong marker in a Korean population
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
HLA association in aspirin-int ...... marker in a Korean population
@ast
HLA association in aspirin-int ...... marker in a Korean population
@en
HLA association in aspirin-int ...... marker in a Korean population
@nl
type
label
HLA association in aspirin-int ...... marker in a Korean population
@ast
HLA association in aspirin-int ...... marker in a Korean population
@en
HLA association in aspirin-int ...... marker in a Korean population
@nl
prefLabel
HLA association in aspirin-int ...... marker in a Korean population
@ast
HLA association in aspirin-int ...... marker in a Korean population
@en
HLA association in aspirin-int ...... marker in a Korean population
@nl
P2093
P3181
P1476
HLA association in aspirin-int ...... marker in a Korean population
@en
P2093
Choon Sik Park
Heung Bum Oh
Jeong Hee Choi
Kwan Jeh Lee
Kyung Wha Lee
Yu Jin Suh
P3181
P356
10.1016/J.JACI.2003.12.012
P407
P50
P577
2004-03-01T00:00:00Z